| Allison June Strakey, APRN | |
|
5876 S Kingston Way, Murray, UT 84107-6142 | |
| (435) 650-3076 | |
| Not Available |
| Full Name | Allison June Strakey |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 5876 S Kingston Way, Murray, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578158952 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 5196241-4405 (Utah) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 5196241-4405 (Utah) | Primary |
| Entity Name | University Of Utah Acuity Care Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407250541 PECOS PAC ID: 4789908534 Enrollment ID: O20150127000392 |
News Archive
Trius Therapeutics, Inc. announced that on February 26th, 2010, the FDA issued new draft guidance on non-inferiority clinical trials that will apply to the design of the Company's proposed Phase 3 trials for its investigational antibacterial drug torezolid phosphate.
Human Genome Sciences (HGS) and GlaxoSmithKline (GSK) today announced positive results from BLISS-76, the second of two large-scale phase III clinical trials of BENLYSTA(TM) (belimumab) for treating systemic lupus. A full presentation of results from BLISS-52 was recently shared at the 73rd Annual Scientific meeting of the American College of Rheumatology. Both trials succeeded in meeting their primary endpoints, which should make BENLYSTA eligible for approval by the U.S. Food and Drug Administration (FDA).
Sorin Group, a global company and a leader in the treatment of cardiovascular diseases, announced today that it has entered into a distribution agreement, effective May 1, 2010, with CardioMedical GmbH, making Sorin Group, CardioMedical's selected partner for the entire Cardio Vision™ MIS Portfolio which is a comprehensive catalogue of minimally invasive cardiac surgery instruments and accessories.
Researchers at Marcus Autism Center, Children's Healthcare of Atlanta and Emory University School of Medicine have identified signs of autism present in the first months of life.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Allison June Strakey, APRN 5876 S Kingston Way, Murray, UT 84107-6142 Ph: (435) 650-3076 | Allison June Strakey, APRN 5876 S Kingston Way, Murray, UT 84107-6142 Ph: (435) 650-3076 |
News Archive
Trius Therapeutics, Inc. announced that on February 26th, 2010, the FDA issued new draft guidance on non-inferiority clinical trials that will apply to the design of the Company's proposed Phase 3 trials for its investigational antibacterial drug torezolid phosphate.
Human Genome Sciences (HGS) and GlaxoSmithKline (GSK) today announced positive results from BLISS-76, the second of two large-scale phase III clinical trials of BENLYSTA(TM) (belimumab) for treating systemic lupus. A full presentation of results from BLISS-52 was recently shared at the 73rd Annual Scientific meeting of the American College of Rheumatology. Both trials succeeded in meeting their primary endpoints, which should make BENLYSTA eligible for approval by the U.S. Food and Drug Administration (FDA).
Sorin Group, a global company and a leader in the treatment of cardiovascular diseases, announced today that it has entered into a distribution agreement, effective May 1, 2010, with CardioMedical GmbH, making Sorin Group, CardioMedical's selected partner for the entire Cardio Vision™ MIS Portfolio which is a comprehensive catalogue of minimally invasive cardiac surgery instruments and accessories.
Researchers at Marcus Autism Center, Children's Healthcare of Atlanta and Emory University School of Medicine have identified signs of autism present in the first months of life.
› Verified 8 days ago